Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT07025538 · RECRUITING
Trial details
- NCT number
- NCT07025538
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2028-06-22
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.